Two years on dutasteride and minoxidil
    3/21/2025

    From the encyclopedia
    Dutasteride →

    Heavy duty finasteride that comes with higher risks

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 Dutasteride (oral) 0.5 mg 2 years
    💊 Minoxidil (oral) 2.5 mg 2 years
    💉 Testosterone Cypionate (injection) 28-30 mg every other day 3 years
    the tone is 😀 positive with solid gains in the first year, stabilization over the second results.

    Other terms

    The conversation discusses a user's two-year experience using oral dutasteride and minoxidil for hair loss, noting initial gains and stabilization over time, with some concerns about shedding and a weak spot at the crown. The user also mentions using testosterone cypionate and reports no significant side effects, except possibly dry eyes.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

    Related Research

    6 / 6 results

      research Dermatologic care of the transgender patient - eScholarship

      January 2016 in “Dermatology Online Journal”
      This review discusses dermatologic issues specific to transgender patients undergoing hormonal therapy and offers guidance for dermatology providers, but does not report new clinical results.
      Hormonal and Surgical Treatment Options for Transgender Men (Female-to-Male)

      research Hormonal and Surgical Treatment Options for Transgender Men (Female-to-Male)

      26 citations , December 2016 in “Psychiatric Clinics of North America”
      This review describes current medical and surgical treatments for transgender men, highlighting the effectiveness and general tolerability of hormone treatment, and suggesting that surgical benefits often surpass associated risks, although it reports no new clinical findings.
      Advances in Male Hormone Substitution Therapy

      research Advances in male hormone substitution therapy

      23 citations , August 2005 in “Expert opinion on pharmacotherapy”
      This review examines the benefits and potential risks of androgen replacement therapy for male hypogonadism but reports no new clinical results; the authors highlight the need for careful risk assessment, especially in older men.
      Transgender and Migraine: Impact of Hormone Therapy

      research Transgender and Migraine

      7 citations , January 2019 in “Headache”
      This source suggests that migraine prevalence increases in transgender women using oestrogen and decreases in transgender men using testosterone, with high oral oestrogen doses in transgender women potentially linked to aura risk.
      Pharmacology of Anabolic Steroids

      research Pharmacology of anabolic steroids

      441 citations , May 2008 in “British Journal of Pharmacology”
      This article reviews the potential clinical use of anabolic steroids in treating muscle loss from chronic diseases and aging and highlights both the benefits and risks of these substances in sports.
      Pharmacodynamic Evaluation: Endocrinology

      research Pharmacodynamic Evaluation: Endocrinology

      January 2017
      This chapter reviews pharmacodynamic evaluations in endocrine disorders focusing on oral antidiabetics, insulin analogues, and hormone interactions, but reports no new results.